相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Revving the CAR-Combination strategies to enhance CAR T cell effectiveness
Rajat Bansal et al.
BLOOD REVIEWS (2021)
The Landscape of CAR-T Cell Clinical Trials against Solid Tumors-A Comprehensive Overview
Niels Schaft
CANCERS (2020)
A safe and potent anti-CD19 CAR T cell therapy
Zhitao Ying et al.
NATURE MEDICINE (2019)
Mir526b and Mir655 Promote Tumour Associated Angiogenesis and Lymphangiogenesis in Breast Cancer
Stephanie Hunter et al.
CANCERS (2019)
Variable impact of three different antiangiogenic drugs alone or in combination with chemotherapy on multiple bone marrow-derived cell populations involved in angiogenesis and immunity
Elaine Reguera-Nunez et al.
ANGIOGENESIS (2019)
Multiparametric magnetic resonance imaging in the assessment of anti-EGFRvIII chimeric antigen receptor T cell therapy in patients with recurrent glioblastoma
Sumei Wang et al.
BRITISH JOURNAL OF CANCER (2019)
Phase I study of chimeric antigen receptor modified T cells in treating HER2-positive advanced biliary tract cancers and pancreatic cancers
Kaichao Feng et al.
PROTEIN & CELL (2018)
Activity of Mesothelin-Specific Chimeric Antigen Receptor T Cells Against Pancreatic Carcinoma Metastases in a Phase 1 Trial
Gregory L. Beatty et al.
GASTROENTEROLOGY (2018)
CD33-Specific Chimeric Antigen Receptor T Cells with Different Co-Stimulators Showed Potent Anti-Leukemia Efficacy and Different Phenotype
Saisai Li et al.
HUMAN GENE THERAPY (2018)
Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia
Joseph A. Fraietta et al.
NATURE MEDICINE (2018)
VEGF-C sustains VEGFR2 activation under bevacizumab therapy and promotes glioblastoma maintenance
Signe R. Michaelsen et al.
NEURO-ONCOLOGY (2018)
Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia
Jae H. Park et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
S. L. Maude et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Inhibition of lymphangiogenesis impairs antitumour effects of photodynamic therapy and checkpoint inhibitors in mice
Angelika Muchowicz et al.
EUROPEAN JOURNAL OF CANCER (2017)
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
Christine E. Brown et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Construction of a new anti-CD19 chimeric antigen receptor and the anti-leukemia function study of the transduced T cells
Na An et al.
ONCOTARGET (2016)
Bevacizumab Combined With Weekly Paclitaxel, Pegylated Liposomal Doxorubicin, or Topotecan in Platinum-Resistant Recurrent Ovarian Cancer: Analysis by Chemotherapy Cohort of the Randomized Phase III AURELIA Trial
Andres M. Poveda et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
CD33-specific chimeric antigen receptor T cells exhibit potent preclinical activity against human acute myeloid leukemia
S. S. Kenderian et al.
LEUKEMIA (2015)
Preclinical targeting of human acute myeloid leukemia and myeloablation using chimeric antigen receptor-modified T cells
Saar Gill et al.
BLOOD (2014)
Ramucirumab: Successfully Targeting Angiogenesis in Gastric Cancer
Milind Javle et al.
CLINICAL CANCER RESEARCH (2014)
Anti-CD22-chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia
Waleed Haso et al.
BLOOD (2013)
Specificity redirection by CAR with human VEGFR-1 affinity endows T lymphocytes with tumor-killing ability and anti-angiogenic potency
W. Wang et al.
GENE THERAPY (2013)
Receptor Activator for NF-κB Ligand in Acute Myeloid Leukemia: Expression, Function, and Modulation of NK Cell Immunosurveillance
Benjamin Joachim Schmiedel et al.
JOURNAL OF IMMUNOLOGY (2013)
Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia
Sarah J. Conley et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Chimeric Antigen Receptor-Modified T Cells in Chronic Lymphoid Leukemia
David L. Porter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
A Computational Tool for Quantitative Analysis of Vascular Networks
Enrique Zudaire et al.
PLOS ONE (2011)
Gene therapy using genetically modified lymphocytes targeting VEGFR-2 inhibits the growth of vascularized syngenic tumors in mice
Dhanalakshmi Chinnasamy et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Targeting the tumour vasculature: insights from physiological angiogenesis
Alicia S. Chung et al.
NATURE REVIEWS CANCER (2010)
An Anti-Vascular Endothelial Growth Factor Receptor 2/Fetal Liver Kinase-1 Listeria monocytogenes Anti-Angiogenesis Cancer Vaccine for the Treatment of Primary and Metastatic Her-2/neu+ Breast Tumors in a Mouse Model
Matthew M. Seavey et al.
JOURNAL OF IMMUNOLOGY (2009)
The role of the VEGF-C/VEGFR-3 axis in cancer progression
J-L Su et al.
BRITISH JOURNAL OF CANCER (2007)
Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer
Alan Sandler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Inhibtion of VEGFR-3 activation with the antagonistic antibody more potently suppresses lymph node and distant metastases than inactivation of VEGFR-2
N Roberts et al.
CANCER RESEARCH (2006)
Synergy between tumor immunotherapy and antiangiogenic therapy
S Nair et al.
BLOOD (2003)
The biology of VEGF and its receptors
N Ferrara et al.
NATURE MEDICINE (2003)
Overexpression of vascular endothelial growth factor (VEGF) and its cellular receptor KDR (VEGFR-2) in the bone marrow of patients with acute myeloid leukemia
T Padró et al.
LEUKEMIA (2002)
Active immunization against the vascular endothelial growth factor receptor flk1 inhibits tumor angiogenesis and metastasis
YW Li et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Vascular endothelial growth factor (VEGF) is an autocrine growth factor for VEGF receptor-positive human tumors
R Masood et al.
BLOOD (2001)
Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis
SJ Mandriota et al.
EMBO JOURNAL (2001)
Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3
T Mäkinen et al.
NATURE MEDICINE (2001)
De novo expression of vascular endothelial growth factor in human pancreatic cancer:: Evidence for an autocrine mitogenic loop
Z Von Marschall et al.
GASTROENTEROLOGY (2000)
VEGF, flt-1, and KDR/flk-1 as prognostic indicators in endometrial carcinoma
BA Fine et al.
GYNECOLOGIC ONCOLOGY (2000)
分享论文
